Literature DB >> 6631863

Oculomotor abnormalities related to otolith function: discussion paper.

M Gresty.   

Abstract

Entities:  

Mesh:

Year:  1983        PMID: 6631863      PMCID: PMC1439624          DOI: 10.1177/014107688307601011

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   18.000


× No keyword cloud information.
  14 in total

1.  The pathology symptomatology and diagnosis of certain common disorders of the vestibular system.

Authors:  M R DIX; C S HALLPIKE
Journal:  Proc R Soc Med       Date:  1952-06

2.  Pontine abscess: survival following surgical drainage. Case report.

Authors:  J C VanGilder; W E Allen; R A Lesser
Journal:  J Neurosurg       Date:  1974-03       Impact factor: 5.115

3.  Down-beat nystagmus.

Authors:  D G Cogan
Journal:  Arch Ophthalmol       Date:  1968-12

4.  Canal-otolith convergence on cat ocular motoneurons.

Authors:  W Precht; J H Anderson; R H Blanks
Journal:  Prog Brain Res       Date:  1979       Impact factor: 2.453

5.  The ocular tilt reaction--a brainstem oculomotor routine.

Authors:  G Westheimer; S M Blair
Journal:  Invest Ophthalmol       Date:  1975-11

6.  Upbeat nystagmus and internuclear ophthalmoplegia with brainstem glioma.

Authors:  B T Troost; J Martinez; L A Abel; R C Heros
Journal:  Arch Neurol       Date:  1980-07

7.  Elicitation of horizontal nystagmus by periodic linear acceleration.

Authors:  J I Niven; W C Hixson; M J Correia
Journal:  Acta Otolaryngol       Date:  1966 Oct-Nov       Impact factor: 1.494

8.  Ocular skew deviation. Analysis of 100 cases.

Authors:  J R Keane
Journal:  Arch Neurol       Date:  1975-03

9.  Physiology of peripheral neurons innervating otolith organs of the squirrel monkey. III. Response dynamics.

Authors:  C Fernández; J M Goldberg
Journal:  J Neurophysiol       Date:  1976-09       Impact factor: 2.714

10.  Primary position upbeat nystagmus. A clinicopathologic study.

Authors:  N Gilman; R W Baloh; U Tomiyasu
Journal:  Neurology       Date:  1977-03       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.